Fonte: Psychoneuroendocrinology. Unidade: FM
Assuntos: BIOMARCADORES, INFLAMAÇÃO, TRANSTORNOS COGNITIVOS, ESTUDOS LONGITUDINAIS, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, RESISTÊNCIA À INSULINA
ABNT
CEZARETTO, Adriana et al. Utility of combined inflammatory biomarkers for the identification of cognitive dysfunction in non-diabetic participants of the ELSA-Brasil. Psychoneuroendocrinology, v. 103, p. 61-66, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.psyneuen.2019.01.003. Acesso em: 16 nov. 2024.APA
Cezaretto, A., Almeida-pititto, B. de, Alencar, G. P., Suemoto, C. K., Benseñor, I. J. M., Lotufo, P. A., et al. (2019). Utility of combined inflammatory biomarkers for the identification of cognitive dysfunction in non-diabetic participants of the ELSA-Brasil. Psychoneuroendocrinology, 103, 61-66. doi:10.1016/j.psyneuen.2019.01.003NLM
Cezaretto A, Almeida-pititto B de, Alencar GP, Suemoto CK, Benseñor IJM, Lotufo PA, Ferreira SRG, Aquino EML, Mota ELA, Barreto SM. Utility of combined inflammatory biomarkers for the identification of cognitive dysfunction in non-diabetic participants of the ELSA-Brasil [Internet]. Psychoneuroendocrinology. 2019 ; 103 61-66.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.psyneuen.2019.01.003Vancouver
Cezaretto A, Almeida-pititto B de, Alencar GP, Suemoto CK, Benseñor IJM, Lotufo PA, Ferreira SRG, Aquino EML, Mota ELA, Barreto SM. Utility of combined inflammatory biomarkers for the identification of cognitive dysfunction in non-diabetic participants of the ELSA-Brasil [Internet]. Psychoneuroendocrinology. 2019 ; 103 61-66.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.psyneuen.2019.01.003